Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05218850
PHASE1
The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
Sponsor: Children's Hospital Los Angeles
View on ClinicalTrials.gov
Summary
Butyrate is an important metabolite produced by the gut microbiome and has been shown as a helpful therapy in ulcerative colitis. This is a feasibility study to determine the efficacy of butryate enemas in pediatric ulcerative colitis.
Official title: Butyrate Therapy in Hispanic Children With Ulcerative Colitis
Key Details
Gender
All
Age Range
7 Years - 21 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2022-06-29
Completion Date
2027-06-30
Last Updated
2024-04-18
Healthy Volunteers
No
Conditions
Interventions
DRUG
Butyrate
Butyrate enemas will be administered once a day for 12 weeks
Locations (1)
Children's Hospital Los Angeles
Los Angeles, California, United States